Dr. Davies on Personalizing Treatment in Relapsed/Refractory Myeloma

Faith E. Davies, MD, a professor in the Department of Medicine and director of the Clinical Myeloma Program at NYU Langone Health’s Perlmutter Cancer Center, shares advice on how to best treat patients with relapsed/refractory multiple myeloma.

Patients with relapsed/refractory multiple myeloma should be monitored closely, says Davies. It is also important to be proactive when patients relapse, to remember that a wrong answer does not exist, and that each patient is different, adds Davies. Knowing what treatment patients have received before, what adverse events they had from that treatment, and what problems they have now will allow for personalized therapy for each individual patient; this will ensure that patients are given the best treatment possible at that particular point in their treatment journey, concludes Davies.